🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
839 medicines starting with “P”
MedicineActive substanceLicence holderStatus
Pegasys 180 micrograms solution for injection
EU/1/02/221/003-004
Peginterferon-alfa-2a pharmaand GmbH
Peglax 10 g powder for oral solution in sachet
PA2028/003/001
Macrogol 4000 Casen-Recordati S.L. Not marketed
Peiotal 25 microgram/125 microgram/dose pressurised inhalation, suspension
PA23010/001/002
Salmeterol, Fluticasone propionate Genetic S.p.A. Not marketed
Peiotal 25 microgram/250 microgram/dose pressurised inhalation, suspension
PA23010/001/003
Salmeterol, Fluticasone propionate Genetic S.p.A. Not marketed
Peiotal 25 microgram/50 microgram/dose pressurised inhalation, suspension
PA23010/001/001
Salmeterol, Fluticasone propionate Genetic S.p.A. Not marketed
Pelgraz 6 mg Solution for injection
EU/1/18/1313/001
Pegfilgrastim Accord Healthcare S.L.U.
Pelmeg 6 mg solution for injection in pre-filled syringe
EU/1/18/1328/001
Pegfilgrastim Mundipharma Corporation (Ireland) Limited
Pemazyre 13.5 mg tablets
EU/1/21/1535/005-006
Pemigatinib Incyte Biosciences Distribution B.V.
Pemazyre 4.5 mg tablets
EU/1/21/1535/001-002
Pemigatinib Incyte Biosciences Distribution B.V.
Pemazyre 9 mg tablets
EU/1/21/1535/003-004
Pemigatinib Incyte Biosciences Distribution B.V.
Pemetrexed 25 mg/ml concentrate for solution for infusion
PA1082/004/001
Pemetrexed BioOrganics BV Not marketed
Pemetrexed Accord 100 mg powder for concentrate for solution for infusion
EU/1/15/1071/001
Pemetrexed disodium, Pemetrexed Accord Healthcare S.L.U.
Pemetrexed Accord 1000 mg powder for concentrate for solution for infusion
EU/1/15/1071/003
Pemetrexed, Pemetrexed disodium Accord Healthcare S.L.U.
Pemetrexed Accord 25 mg/ml concentrate for solution for infusion
EU/1/15/1071/004-007
Pemetrexed, Pemetrexed Disodium Hemipentahydrate Accord Healthcare S.L.U.
Pemetrexed Accord 500 mg powder for concentrate for solution for infusion
EU/1/15/1071/002
Pemetrexed disodium, Pemetrexed Accord Healthcare S.L.U.
Pemetrexed Baxter 100 mg powder for concentrate for solution for infusion
EU/1/22/1705/001
Pemetrexed disodium heptahydrate Baxter Holding B.V.
Pemetrexed Baxter 500 mg powder for concentrate for solution for infusion
EU/1/22/1705/002
Pemetrexed disodium heptahydrate Baxter Holding B.V.
Pemetrexed Clonmel 25 mg/ml concentrate for solution for infusion
PA0126/270/001
Pemetrexed Disodium 2.5 hydrate Clonmel Healthcare Ltd Marketed
Pemetrexed EVER Pharma 25 mg/ml concentrate for solution for infusion
PA1774/005/001
Pemetrexed EVER Valinject GmbH Marketed
Pemetrexed Fresenius Kabi 100 mg powder for concentrate for solution for infusion
EU/1/16/1115/001
Pemetrexed Fresenius Kabi Deutschland GmbH
Pemetrexed Fresenius Kabi 25 mg/ml concentrate for solution for infusion
EU/1/16/1115/003-005
Pemetrexed Fresenius Kabi Deutschland GmbH
Pemetrexed Fresenius Kabi 500 mg powder for concentrate for solution for infusion
EU/1/16/1115/002
Pemetrexed Fresenius Kabi Deutschland GmbH
Pemetrexed Lilly
EU/1/15/1034/001
Pemetrexed disodium heptahydrate Eli Lilly Nederland B.V.
Pemetrexed Lilly
EU/1/15/1034/002
Pemetrexed disodium heptahydrate Eli Lilly Nederland B.V.
Pemetrexed medac 1,000 mg powder for concentrate for solution for infusion
EU/1/15/1038/003
Pemetrexed medac Gesellschaft für klinische Spezialpräparate mbH
Pemetrexed medac 100 mg powder for concentrate for solution for infusion
EU/1/15/1038/001
Pemetrexed medac Gesellschaft für klinische Spezialpräparate mbH
Pemetrexed medac 500 mg powder for concentrate for solution for infusion
EU/1/15/1038/002
Pemetrexed medac Gesellschaft für klinische Spezialpräparate mbH
Pemetrexed Pfizer 1,000 mg powder for concentrate for solution for infusion
EU/1/15/1057/003
Pemetrexed disodium Pfizer Europe MA EEIG
Pemetrexed Pfizer 1,000 mg powder for concentrate for solution for infusion
EU/1/17/1183/003
Pemetrexed ditromethamine Pfizer Europe MA EEIG
Pemetrexed Pfizer 100 mg powder for concentrate for solution for infusion
EU/1/15/1057/001
Pemetrexed disodium Pfizer Europe MA EEIG
Pemetrexed Pfizer 100 mg powder for concentrate for solution for infusion
EU/1/17/1183/001
Pemetrexed ditromethamine Pfizer Europe MA EEIG
Pemetrexed Pfizer 25 mg/ml concentrate for solution for infusion
EU/1/15/1057/004-006
Pemetrexed Disodium Hemipentahydrate, Pemetrexed Pfizer Europe MA EEIG
Pemetrexed Pfizer 500 mg powder for concentrate for solution for infusion
EU/1/15/1057/002
Pemetrexed disodium Pfizer Europe MA EEIG
Pemetrexed Pfizer 500 mg powder for concentrate for solution for infusion
EU/1/17/1183/002
Pemetrexed ditromethamine Pfizer Europe MA EEIG
Pemetrexed Seacross 100 mg powder for concentrate for solution for infusion
PA22766/002/001
Pemetrexed Seacross Pharma (Europe) Limited Not marketed
Pemetrexed Seacross 500 mg powder for concentrate for solution for infusion
PA22766/002/002
Pemetrexed Seacross Pharma (Europe) Limited Not marketed
Pemetrexed Viatris 25 mg/ml concentrate for solution for infusion
PA23266/068/001
Pemetrexed Viatris Limited Not marketed
Pendrex 2mg tablets
PA0711/118/001
Perindopril tert-butylamine Rowex Ltd Marketed
Pendrex 4mg tablets
PA0711/118/002
Perindopril tert-butylamine Rowex Ltd Marketed
Pendrex 8 mg tablets
PA0711/118/004
Perindopril tert-butylamine Rowex Ltd Marketed
Pendrex Plus 4mg/1.25mg tablets
PA0711/171/001
Indapamide, Perindopril tert-butylamine Rowex Ltd Marketed
Pentamidine Tillomed 300 mg powder for solution for injection/infusion or powder for nebuliser solution
PA22720/013/001
Pentamidine isethionate Tillomed Pharma GmbH Not marketed
Pentasa 1 g prolonged-release tablets
PA1009/006/007
Mesalazine Ferring Ireland Ltd Marketed
Pentasa 1 g prolonged-release tablets
PPA1463/110/002
Mesalazine IMED Healthcare Ltd.
Pentasa 1 g prolonged-release tablets
PPA0465/450/003
Mesalazine PCO Manufacturing Ltd.
Pentasa 1 g suppositories
PPA2306/010/001
Mesalazine Originalis B.V.
Pentasa 1 g Suppositories
PPA1463/190/003
Mesalazine IMED Healthcare Ltd.,
Pentasa 10 mg/ml Rectal Suspension
PA1009/006/003
Mesalazine Ferring Ireland Ltd Marketed
Pentasa 1g Suppositories
PA1009/006/002
Mesalazine Ferring Ireland Ltd Marketed
Pentasa 1g Suppositories
PPA0465/450/005
Mesalazine PCO Manufacturing Ltd.
2 3 4 5 6 7 8

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.